We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$57.5B
AUM Growth
+$5.01B
(+9.6%)
Cap. Flow
+$1.1B
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
17.86%
Holding
2,535
New
397
Increased
862
Reduced
813
Closed
353
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$228M |
| 2 |
Boston Scientific
BSX
|
+$177M |
| 3 |
Meta Platforms (Facebook)
META
|
+$154M |
| 4 |
NVIDIA
NVDA
|
+$142M |
| 5 |
Amazon
AMZN
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$441M |
| 2 |
Humana
HUM
|
+$131M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 4 |
Electronic Arts
EA
|
+$116M |
| 5 |
Clorox
CLX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Consumer Discretionary | 10.13% |
| 3 | Healthcare | 10.11% |
| 4 | Financials | 9.99% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Organon & Co
OGN
$3.55B
| $322K | ﹤0.01% |
30,137
-38,081
| -56% | -$374K |
|
1877
Pacific Biosciences
PACB
$422M
| $320K | ﹤0.01% |
+250,276
| New | +$339K |
|
1878
Zevra Therapeutics
ZVRA
$563M
| $320K | ﹤0.01% |
+33,652
| New | +$337K |
|
1879
CALL
Capital One
COF
$124B
| $319K | ﹤0.01% |
+1,500
| New | +$328K |
|
1880
Apogee Enterprises
APOG
$850M
| $319K | ﹤0.01% |
7,316
+1,049
| +17% | +$45K |
|
1881
Mondelez International
MDLZ
$77.7B
| $319K | ﹤0.01% |
5,102
-9,263
| -64% | -$597K |
|
1882
Oil States International
OIS
$522M
| $319K | ﹤0.01% |
+52,591
| New | +$288K |
|
1883
BlackLine
BL
$1.69B
| $317K | ﹤0.01% |
5,967
+1,644
| +38% | +$88.8K |
|
1884
Cricut
CRCT
$936M
| $317K | ﹤0.01% |
+50,334
| New | +$295K |
|
|
BCYC
1885
Bicycle Therapeutics
BCYC
$270M
| $316K | ﹤0.01% |
40,891
+12,216
| +43% | +$92.2K |
|
1886
Enovix
ENVX
$862M
| $316K | ﹤0.01% |
+31,714
| New | +$351K |
|
1887
GH Research
GHRS
$1.87B
| $315K | ﹤0.01% |
+22,060
| New | +$309K |
|
1888
Atlanticus Holdings
ATLC
$1.5B
| $315K | ﹤0.01% |
5,374
-7,424
| -58% | -$448K |
|
1889
EverQuote
EVER
$886M
| $313K | ﹤0.01% |
13,690
-32,215
| -70% | -$778K |
|
1890
Vestis
VSTS
$2.06B
| $312K | ﹤0.01% |
68,952
-192,664
| -74% | -$988K |
|
1891
CALL
DuPont de Nemours
DD
$18.6B
| $312K | ﹤0.01% |
+3,187
| New | +$300K |
|
|
1892
PUT
DuPont de Nemours
DD
$18.6B
| $312K | ﹤0.01% |
+3,187
| New | +$300K |
|
1893
Albany International
AIN
$2.14B
| $311K | ﹤0.01% |
5,835
-5,653
| -49% | -$359K |
|
1894
RPC Inc
RES
$1.24B
| $308K | ﹤0.01% |
64,701
+48,033
| +288% | +$227K |
|
1895
Delcath Systems
DCTH
$422M
| $306K | ﹤0.01% |
28,453
-60,034
| -68% | -$670K |
|
1896
Universal Corp
UVV
$1.34B
| $306K | ﹤0.01% |
+5,469
| New | +$302K |
|
1897
Colony Bankcorp
CBAN
$462M
| $305K | ﹤0.01% |
+17,919
| New | +$306K |
|
|
GRDN
1898
Guardian Pharmacy Services
GRDN
$2.56B
| $301K | ﹤0.01% |
11,492
-17,890
| -61% | -$426K |
|
1899
Monte Rosa Therapeutics
GLUE
$1.92B
| $301K | ﹤0.01% |
40,575
+4,184
| +11% | +$22.2K |
|
1900
OneSpan
OSPN
$562M
| $301K | ﹤0.01% |
18,917
-3,127
| -14% | -$47.6K |
|
Similar funds
Man Group's Q3 2025 Portfolio in Review
As of Q3 2025, Man Group held 2,535 positions worth $57.5B, up 9.6% from $52.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Man Group's Q3 2025 filing shows 397 new, 862 increased, 813 reduced and 353 closed positions. Its largest new stake was TE Connectivity: 347,966 shares worth $76.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Man Group's largest Q3 2025 buy was TE Connectivity: 347,966 shares worth $76.4M.
- Man Group added most to Microsoft in Q3 2025, an estimated $228M increase.
- Man Group's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $441M.
- Man Group fully exited Ansys in Q3 2025, selling an estimated $79.3M.
- Man Group's ten largest holdings make up 18% of its $57.5B portfolio in Q3 2025.
- Man Group opened 397 new positions and closed 353 in Q3 2025.
- Man Group's portfolio value rose 9.6% quarter-over-quarter to $57.5B.
Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.